MedTrace Logo

Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer

NCT02342847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-01-25

No results posted yet for this study

Summary

This is an observational, post-authorization, prospective follow-up, multi-centre, national study designed to describe the spectrum of health-related quality of life in patients with metastatic pancreatic cancer previously untreated with chemotherapy This study is designed to observe patients treated in routine clinical practice, without the exclusion limitations of a clinical trial. Patients will be enrolled in 7 Spanish sites. In all cases, the decision to treat patients will be performed prior to the decision to include the patient in the study.

Given the observational nature of the study, follow-up of patients will be performed according to standard clinical practice of each site.

Conditions

  • Pancreatic Neoplasms

Interventions

OTHER

N/A (non-interventional study)

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • Lorena Pellín, MD · Celgene Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-10
Primary Completion
2016-11-09
Completion
2018-11-16

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342847 on ClinicalTrials.gov